Iconic Therapeutics Initiates Second Phase 2 Study of ICON-1 in Patients With Neovascular (wet) AMD

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--ICONIC starts second Phase 2 study

Full Story →